Cellectis
CLLS
49 hedge funds and large institutions have $23.6M invested in Cellectis in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 4 closing their positions.
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
11% more funds holding
Funds holding: 44 → 49 (+5)
1.18% less ownership
Funds ownership: 23.81% → 22.63% (-1.2%)
27% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 15
44% less capital inflows, than outflows
Capital inflows: $1.96M | Capital outflows: $3.48M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Woodline Partners
San Francisco,
California
|
+$514K |
| 2 |
Millennium Management
New York
|
+$366K |
| 3 |
KHCM
Kettle Hill Capital Management
New York
|
+$317K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$260K |
| 5 |
Baird Financial Group
Milwaukee,
Wisconsin
|
+$98.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bpifrance
Maisons Alfort, Cedex,
France
|
-$1.2M |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$607K |
| 3 |
Jane Street
New York
|
-$443K |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$401K |
| 5 |
LFCM
Long Focus Capital Management
San Juan,
Puerto Rico
|
-$327K |
CLLS Hedge Fund Activity: Q3 2022 in Review
49 of the 5,832 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q3 2022, worth a combined $23.6M — down 23% from $30.6M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new CLLS positions and 4 closed out — a net gain of 5 holders — while 11 added to existing stakes and 15 trimmed.
The largest buyer was Woodline Partners, opening a new position worth an estimated $514K. The largest seller was Bpifrance, exiting entirely with an estimated $1.2M sold.
- 49 institutional investors held Cellectis (CLLS) as of Q3 2022, up from 44 in Q2 2022.
- Funds reported $23.6M of Cellectis stock for Q3 2022, down 23% quarter-over-quarter.
- 9 funds opened new Cellectis positions in Q3 2022 and 4 closed out, a net change of +5 holders.
- The largest Cellectis buyer in Q3 2022 was Woodline Partners, an estimated $514K added.
- The largest Cellectis seller in Q3 2022 was Bpifrance, an estimated $1.2M sold.
Based on aggregated 13F filings for Q3 2022.